NYSEAMERICAN:DXR Daxor (DXR) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free DXR Stock Alerts $9.79 +0.04 (+0.41%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$9.79▼$9.7950-Day Range N/A52-Week Range$7.11▼$13.13Volume477 shsAverage Volume3,387 shsMarket Capitalization$46.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings Get Daxor alerts: Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Daxor Stock (NYSEAMERICAN:DXR)Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.Read More DXR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DXR Stock News HeadlinesApril 16, 2024 | finance.yahoo.comNew Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionApril 15, 2024 | finance.yahoo.comDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)April 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 1, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the American College of Cardiology for ACC.24March 29, 2024 | investing.comDaxor CFO Michel Robert J buys $6.5k in company stockMarch 28, 2024 | money.usnews.comDestiny Tech100 IncMarch 28, 2024 | finance.yahoo.comDaxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | wsj.comDaxor Corp.April 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.March 22, 2024 | finance.yahoo.comDaxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024March 8, 2024 | finance.yahoo.comMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsFebruary 12, 2024 | finance.yahoo.comDaxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsFebruary 9, 2024 | benzinga.comDaxor Stock (NASDAQ:DXR) Insider TradesFebruary 7, 2024 | finance.yahoo.comDaxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsJanuary 29, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingJanuary 16, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressJanuary 9, 2024 | finance.yahoo.comDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESJanuary 3, 2024 | msn.comDaxor seeks US FDA approval for blood volume analyserJanuary 2, 2024 | finance.yahoo.comDaxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNovember 13, 2023 | seekingalpha.comAspira Women’s Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68MNovember 13, 2023 | finanznachrichten.deDaxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure PatientsNovember 13, 2023 | finance.yahoo.comNew Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure PatientsNovember 9, 2023 | finance.yahoo.comDaxor Corporation Awarded New Patent for Remote Monitoring of Blood VolumeNovember 7, 2023 | msn.comNeuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32MNovember 5, 2023 | benzinga.comChief Financial Officer at Daxor Acquires Company Stock Options Worth 5,000 SharesOctober 13, 2023 | finance.yahoo.comExpert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific MeetingOctober 11, 2023 | finance.yahoo.comNew Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific MeetingSee More Headlines Receive DXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolNYSEAMERICAN:DXR Previous SymbolNYSE:DXR CUSIPN/A CIK27367 Webwww.daxor.com Phone(865) 425-0555Fax212-244-0806EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,740,000Free Float1,866,000Market Cap$46.40 million OptionableNot Optionable Beta-0.50 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Michael Richard Feldschuh (Age 55)Chairman, President & CEO Comp: $100kMr. Jonathan Adam Feldschuh (Age 59)Chief Scientific Officer & Director Comp: $127.92kMr. Robert J. Michel CPA (Age 67)CPA, M.B.A., CFO, Chief Compliance Officer & Corporate Secretary Ms. Linda CooperVice President of Development & OperationsMs. Kathryn A. KornafelSenior VP of Marketing & Commercial DevelopmentMr. Guido ManzoVice President of SalesMs. Jean OertelSenior Vice President Commercialization & Customer ExperienceMore ExecutivesKey CompetitorsBionano GenomicsNASDAQ:BNGOPro-DexNASDAQ:PDEXNabriva TherapeuticsNASDAQ:NBRVXilio TherapeuticsNASDAQ:XLONextCureNASDAQ:NXTCView All Competitors DXR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Daxor own? Based on aggregate information from My MarketBeat watchlists, some companies that other Daxor investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), ContraFect (CFRX), Dynavax Technologies (DVAX), iBio (IBIO), Micron Technology (MU) and How do I buy shares of Daxor? Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:DXR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
